Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Erythrocyte membrane-bound ATPases are integral membrane proteins that actively transport ions across the red blood cell membrane, primarily the Na+/K+-ATPase. They maintain ion gradients essential for cell volume regulation and overall erythrocyte function. Their activity is modulated by the lipid environment, oxidative stress, and glycation. Alterations in ATPase activities are linked to diabetes mellitus, oxidative stress conditions, and disorders affecting electrolyte balance or red cell survival. These ATPases are vital for maintaining red blood cell integrity by regulating ion homeostasis and supporting mechanical properties necessary for effective circulation through microvasculature.
Inhibition of Na+/K+-ATPase activity (Ouabain); Restoration of Na+/K+-ATPase activity and RBC deformability (C-peptide)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Erythrocyte Membrane-bound ATPase (N/A).